Diagnostic Applications of Nuclear Magnetic Resonance–Based Urinary Metabolomics. (3rd March 2017)

• Record Type: Journal Article
• Authors: Capati, Ana; Ijare, Omkar B; Bezabeh, Tedros
• Is Part Of: Magnetic resonance insights. Number 10(2017)
• Publication Date: 2017-03-03
• Subjects: Diagnosis -- metabolomics -- NMR spectroscopy -- urine; Diagnostic imaging -- Periodicals; Magnetic resonance imaging -- Periodicals; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Diagnostic Imaging; Diagnostic imaging; Magnetic resonance imaging; Electronic journals; Periodicals; Electronic journals; Periodicals; 538.3605
• DOI: 10.1177/1178623X17694346
• Languages: English
• ISSNs: 1178-623X

Abstract

Metabolomics is a rapidly growing field with potential applications in various disciplines. In particular, metabolomics has received special attention in the discovery of biomarkers and diagnostics. This is largely due to the fact that metabolomics provides critical information related to the downstream products of many cellular and metabolic processes which could provide a snapshot of the health/disease status of a particular tissue or organ. Many of these cellular products eventually find their way to urine; hence, analysis of urine via metabolomics has the potential to yield useful diagnostic and prognostic information. Although there are a number of analytical platforms that can be used for this purpose, this review article will focus on nuclear magnetic resonance–based metabolomics. Furthermore, although there have been many studies addressing different diseases and metabolic disorders, the focus of this review article will be in the following specific applications: urinary tract infection, kidney transplant rejection, diabetes, some types of cancer, and inborn errors of metabolism. A number of methodological considerations that need to be taken into account for the development of a clinically useful optimal test are discussed briefly.